Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Hanwen Liu, Yanwen Li, Maogang Li, Linghai Xie, Feng Li, Runmei Pan & Fang Pei. (2023) Follistatin-like 1 protects endothelial function in the spontaneously hypertensive rat by inhibition of endoplasmic reticulum stress through AMPK-dependent mechanism. Clinical and Experimental Hypertension 45:1.
Read now
Read now
Koji Suzuki, Hiroya Yamada, Ryosuke Fujii, Eiji Munetsuna, Mirai Yamazaki, Yoshitaka Ando, Koji Ohashi, Hiroaki Ishikawa, Genki Mizuno, Yohiski Tsuboi, Shuji Hashimoto & Nobuyuki Hamajima. (2022) Circulating microRNA-27a and -133a are negatively associated with incident hypertension: a five-year longitudinal population-based study. Biomarkers 27:5, pages 496-502.
Read now
Read now
Sonat Pınar Kara, Gulsum Ozkan, Ahsen Yılmaz, Nergiz Bayrakçı, Savaş Güzel & Elif Geyik. (2021) MicroRNA 21 and microRNA 155 levels in resistant hypertension, and their relationships with aldosterone. Renal Failure 43:1, pages 676-683.
Read now
Read now
Ligia Petrica, Agneta-Maria Pusztai, Mihaela Vlad, Adrian Vlad, Florica Gadalean, Victor Dumitrascu, Daliborca Vlad, Silvia Velciov, Cristina Gluhovschi, Flaviu Bob, Sorin Ursoniu, Maxim Petrica, Petru Matusz, Octavian Cretu, Daniela Radu, Oana Milas, Alina Secara, Anca Simulescu, Roxana Popescu & Dragos Catalin Jianu. (2020) MiRNA Expression is Associated with Clinical Variables Related to Vascular Remodeling in the Kidney and the Brain in Type 2 Diabetes Mellitus Patients. Endocrine Research 45:2, pages 119-130.
Read now
Read now
Articles from other publishers (59)
Yazmín Estela Torres-Paz, Ricardo Gamboa, Giovanny Fuentevilla-Álvarez, María Elena Soto, Nadia González-Moyotl, Rocío Martínez-Alvarado, Margarita Torres-Tamayo, Edgar Samuel Ramírez-Marroquín, Xicoténcatl Vásquez-Jiménez, Víctor Sainz-Escarrega & Claudia Huesca-Gómez. (2023) Overexpression of microRNA-21-5p and microRNA-221-5p in Monocytes Increases the Risk of Developing Coronary Artery Disease. International Journal of Molecular Sciences 24:10, pages 8641.
Crossref
Crossref
Lucía Matute-Blanco, Diego Fernández-Rodríguez, Juan Casanova-Sandoval, Thalía Belmonte, Iván D. Benítez, Kristian Rivera, Marcos Garcia-Guimaraes, Carlos Cortés Villar, Vicente Peral Disdier, Raúl Millán Segovia, Ignacio Barriuso, David de Gonzalo-Calvo, Ferran Barbé & Fernando Worner. (2023) Study protocol for the epigenetic characterization of angor pectoris according to the affected coronary compartment: Global and comprehensive assessment of the relationship between invasive coronary physiology and microRNAs. PLOS ONE 18:5, pages e0283097.
Crossref
Crossref
Maria Bergami, Natalia Fabin, Edina Cenko, Raffaele Bugiardini & Olivia Manfrini. (2023) MicroRNAs as Potential Biomarkers in Coronary Artery Disease. Current Topics in Medicinal Chemistry 23:6, pages 454-469.
Crossref
Crossref
Zeyidan Jiapaer, Chengyu Li, Xinyu Yang, Lingfei Sun, Emeli Chatterjee, Lingying Zhang, Ji Lei & Guoping Li. (2023) Extracellular Non-Coding RNAs in Cardiovascular Diseases. Pharmaceutics 15:1, pages 155.
Crossref
Crossref
Vladana Stojiljković, Nikola Stefanović, Marija Vukelić-Nikolić, Branka Đorđević, Jelena Bašić, Gordana Kocić & Tatjana Cvetković. (2023) MicroRNA: Potential biomarkers in chronic kidney disease. Acta Facultatis Medicae Naissensis 40:3, pages 270-278.
Crossref
Crossref
Hui-Yu Luo, Gan Li, Yu-Guo Liu, Yuan-Hao Wei, Jun-Bin Chen, Xiang-Fu Gu, Jia-Qi Tang, Yue Zhao, Chu-Hong Su, Ling-Yu Xiao, Fei Xiong, Zhong-Daixi Zheng, Shi-Ying Wang & Long-Ying Zha. (2022) The Accelerated Progression of Atherosclerosis Correlates with Decreased miR-33a and miR-21 and Increased miR-122 and miR-3064-5p in Circulation and the Liver of ApoE-/- Mice with Streptozocin (STZ)-Induced Type 2 Diabetes. Current Issues in Molecular Biology 44:10, pages 4822-4837.
Crossref
Crossref
Trenton E. Banks, Maheshinie Rajapaksha, Li-Hui Zhang, Feng Bai, Ning-Ping Wang & Zhi-Qing Zhao. (2022) Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension. European Journal of Pharmacology 927, pages 175048.
Crossref
Crossref
Domenico Rendina, Lanfranco D′Elia, Veronica Abate, Andrea Rebellato, Ilaria Buondonno, Mariangela Succoio, Fabio Martinelli, Riccardo Muscariello, Gianpaolo De Filippo, Patrizia D′Amelio, Francesco Fallo, Pasquale Strazzullo & Raffaella Faraonio. (2022) Vitamin D Status, Cardiovascular Risk Profile, and miRNA-21 Levels in Hypertensive Patients: Results of the HYPODD Study. Nutrients 14:13, pages 2683.
Crossref
Crossref
Paul A. Brown. (2022) Differential and targeted vesiculation: pathologic cellular responses to elevated arterial pressure. Molecular and Cellular Biochemistry 477:4, pages 1023-1040.
Crossref
Crossref
Diana Santos & Eugenia Carvalho. (2021) Adipose‐related microRNAs as modulators of the cardiovascular system: the role of epicardial adipose tissue. The Journal of Physiology 600:5, pages 1171-1187.
Crossref
Crossref
Anton A. Raskurazhev, Alla A. Shabalina, Polina I. Kuznetsova & Marine M. Tanashyan. (2022) MicroRNA as significant biomarkers of cerebrovascular atherosclerosis. Annals of Clinical and Experimental Neurology 16:1, pages 5-13.
Crossref
Crossref
Rafał Szelenberger, Michał Seweryn Karbownik, Michał Kacprzak, Karina Maciak, Michał Bijak, Marzenna Zielińska, Piotr Czarny, Tomasz Śliwiński & Joanna Saluk-Bijak. (2021) Screening Analysis of Platelet miRNA Profile Revealed miR-142-3p as a Potential Biomarker in Modeling the Risk of Acute Coronary Syndrome. Cells 10:12, pages 3526.
Crossref
Crossref
Kristina R. Gopcevic, Eugenia Gkaliagkousi, János Nemcsik, Ömür Acet, M. Rosa Bernal-Lopez, Rosa M. Bruno, Rachel E. Climie, Nikolaos Fountoulakis, Emil Fraenkel, Antonios Lazaridis, Petras Navickas, Keith D. Rochfort, Agnė Šatrauskienė, Jūratė Zupkauskienė & Dimitrios Terentes-Printzios. (2021) Pathophysiology of Circulating Biomarkers and Relationship With Vascular Aging: A Review of the Literature From VascAgeNet Group on Circulating Biomarkers, European Cooperation in Science and Technology Action 18216. Frontiers in Physiology 12.
Crossref
Crossref
Jing Zhang, Ming-yan Yao, Guo-rui Zhang, Xian-ru Chen, Qi Liu, Yifang Guo & Xin-wei Jia. (2021) Effects of different enantiomers of amlodipine on lipid profiles and vasomotor factors in atherosclerotic rabbits. Open Life Sciences 16:1, pages 899-908.
Crossref
Crossref
Yongjie Xu, Xunhe Huang, Qingbin Luo & Xiquan Zhang. (2021) MicroRNAs Involved in Oxidative Stress Processes Regulating Physiological
and Pathological Responses. MicroRNA 10:3, pages 164-180.
Crossref
Crossref
Fabiola Olivieri, Francesco Prattichizzo, Angelica Giuliani, Giulia Matacchione, Maria Rita Rippo, Jacopo Sabbatinelli & Massimiliano Bonafè. (2021) miR-21 and miR-146a: The microRNAs of inflammaging and age-related diseases. Ageing Research Reviews 70, pages 101374.
Crossref
Crossref
Don M. Matshazi, Cecil J. Weale, Rajiv T. Erasmus, Andre P. Kengne, Saarah F. G. Davids, Shanel Raghubeer, Stanton Hector, Glenda M. Davison & Tandi E. Matsha. (2021) MicroRNA Profiles in Normotensive and Hypertensive South African Individuals. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Paulina Pei Suu Tan, Deborah Hall, William M. Chilian, Yook Chin Chia, Shamsul Mohd Zain, Hooi Min Lim, Devaraj Navin Kumar, Siew Mooi Ching, Teck Yew Low, Mohd Fairulnizal Md Noh & Yuh-Fen Pung. (2021) Exosomal microRNAs in the development of essential hypertension and its potential as biomarkers. American Journal of Physiology-Heart and Circulatory Physiology 320:4, pages H1486-H1497.
Crossref
Crossref
Pelin Telkoparan-Akillilar & Dilek Cevik. (2021) Identification of miR-17, miR-21, miR-27a, miR-106b and miR-222 as endoplasmic reticulum stress-related potential biomarkers in circulation of patients with atherosclerosis. Molecular Biology Reports 48:4, pages 3503-3513.
Crossref
Crossref
Jhana O. Hendrickx, Wim Martinet, Debby Van Dam & Guido R. Y. De Meyer. (2021) Inflammation, Nitro-Oxidative Stress, Impaired Autophagy, and Insulin Resistance as a Mechanistic Convergence Between Arterial Stiffness and Alzheimer’s Disease. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Yunna Lee & Eunok Im. (2021) Regulation of miRNAs by Natural Antioxidants in Cardiovascular Diseases: Focus on SIRT1 and eNOS. Antioxidants 10:3, pages 377.
Crossref
Crossref
Wenji Sheng, Yang Gu, Xiaodan Chu, John A. Morgan, Danielle B. Cooper, David F. Lewis, Charles E. McCathran & Yuping Wang. (2020) Upregulation of histone H3K9 methylation in fetal endothelial cells from preeclamptic pregnancies. Journal of Cellular Physiology 236:3, pages 1866-1874.
Crossref
Crossref
静 刘. (2021) The Mechanism and Research Progress of miRNA-21 in Diabetic Kidney Disease. Advances in Clinical Medicine 11:12, pages 6169-6176.
Crossref
Crossref
Olga Martinez-Arroyo, Ana Ortega, Josep Redon & Raquel Cortes. (2021) Therapeutic Potential of Extracellular Vesicles in Hypertension-Associated Kidney Disease. Hypertension 77:1, pages 28-38.
Crossref
Crossref
Koji Suzuki, Hiroya Yamada, Ryosuke Fujii, Eiji Munetsuna, Yoshitaka Ando, Koji Ohashi, Hiroaki Ishikawa, Mirai Yamazaki, Keisuke Maeda, Shuji Hashimoto & Nobuyuki Hamajima. (2021) Association between circulating vascular-related microRNAs and an increase in blood pressure: a 5-year longitudinal population-based study. Journal of Hypertension 39:1, pages 84-89.
Crossref
Crossref
Micaela Gliozzi, Vincenzo Musolino, Francesca Bosco, Miriam Scicchitano, Federica Scarano, Saverio Nucera, Maria Caterina Zito, Stefano Ruga, Cristina Carresi, Roberta Macrì, Lorenza Guarnieri, Jessica Maiuolo, Annamaria Tavernese, Anna Rita Coppoletta, Caterina Nicita, Rocco Mollace, Ernesto Palma, Carolina Muscoli, Catherine Belzung & Vincenzo Mollace. (2021) Cholesterol homeostasis: Researching a dialogue between the brain and peripheral tissues. Pharmacological Research 163, pages 105215.
Crossref
Crossref
Paul HolvoetPaul Holvoet. 2021. Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer. Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer
89
117
.
Adam Włodarski, Justyna Strycharz, Adam Wróblewski, Jacek Kasznicki, Józef Drzewoski & Agnieszka Śliwińska. (2020) The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress. International Journal of Molecular Sciences 21:18, pages 6902.
Crossref
Crossref
Linsey J. F. Peters, Erik A. L. Biessen, Mathias Hohl, Christian Weber, Emiel P. C. van der Vorst & Donato Santovito. (2020) Small Things Matter: Relevance of MicroRNAs in Cardiovascular Disease. Frontiers in Physiology 11.
Crossref
Crossref
Constantina ChalikiopoulouBarbara Jenko BizjanGeorge LeventopoulosKalliopi SmailiTanja BlagusAriadni MentiJohn LiopetasAnne JohnBassam R. AliVita DolzanGeorge N. HahalisGeorge P. PatrinosTheodora Katsila. (2020) Multiomics Analysis Coupled with Text Mining Identify Novel Biomarker Candidates for Recurrent Cardiovascular Events. OMICS: A Journal of Integrative Biology 24:4, pages 205-215.
Crossref
Crossref
Qiulian Zhou, Chao Shi, Yicheng Lv, Chenglin Zhao, Zheng Jiao & Tianhui Wang. (2020) Circulating microRNAs in Response to Exercise Training in Healthy Adults. Frontiers in Genetics 11.
Crossref
Crossref
Qingbin Wu, Xiaochen Yuan, Bingwei Li, Jinna Yang, Ruiqin Han, Honggang Zhang & Ruijuan Xiu. (2020) Differential miRNA expression analysis of extracellular vesicles from brain microvascular pericytes in spontaneous hypertensive rats. Biotechnology Letters 42:3, pages 389-401.
Crossref
Crossref
Alejandro Cardona-Monzonís, José Luis García-Giménez, Salvador Mena-Mollá, Helios Pareja-Galeano, Fernando de la Guía-Galipienso, Giuseppe Lippi, Federico V. Pallardó & Fabian Sanchis-Gomar. 2020. Non-coding RNAs in Cardiovascular Diseases. Non-coding RNAs in Cardiovascular Diseases
273
285
.
Amela JusicYvan Devaux. (2019) Noncoding RNAs in Hypertension. Hypertension 74:3, pages 477-492.
Crossref
Crossref
Changli Kan, Junjie Cao, Jing Hou, Xiangyang Jing, Yanju Zhu, Jinhuan Zhang, Yanwei Guo & Xuerong Chen. (2019) Correlation of miR-21 and BNP with pregnancy-inducedhypertension complicated with heart failureand the diagnostic value. Experimental and Therapeutic Medicine.
Crossref
Crossref
Perry V. Halushka, Andrew J. GoodwinMarc K. Halushka. (2019) Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers. Annual Review of Pathology: Mechanisms of Disease 14:1, pages 211-238.
Crossref
Crossref
Li-Xian Yeo, Tzu-Hsiang Tseng, Wei-Liang Chen, Tung-Wei Kao, Li-Wei Wu, Wen-Hui Fang, Yaw-Wen Chang & Tao-Chun Peng. (2019) Hypertension control and risk of colonic diverticulosis. Therapeutic Advances in Gastroenterology 12, pages 175628481985573.
Crossref
Crossref
Erkan Yildirim, Emrah Ermis, Samir Allahverdiyev, Hakan Ucar, Serap Yavuzer & Mahir Cengiz. (2019) Circulating miR-21 levels in hypertensive patients with asymptomatic organ damage. Medicine 98:39, pages e17297.
Crossref
Crossref
Chenggui Miao, Jun Chang & Guoxue Zhang. (2018) Recent research progress of microRNAs in hypertension pathogenesis, with a focus on the roles of miRNAs in pulmonary arterial hypertension. Molecular Biology Reports 45:6, pages 2883-2896.
Crossref
Crossref
Hai-na Zhang, Qiao-qiao Xu, Abhimanyu Thakur, Martin Omondi Alfred, Manas Chakraborty, Arunima Ghosh & Xu-ben Yu. (2018) Endothelial dysfunction in diabetes and hypertension: Role of microRNAs and long non-coding RNAs. Life Sciences 213, pages 258-268.
Crossref
Crossref
Fahad Ahmed, Sherin Bakhashab, Inda Bastaman, Rachel Crossland, Michael Glanville & Jolanta Weaver. (2018) Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study. International Journal of Molecular Sciences 19:10, pages 3242.
Crossref
Crossref
Xiao Li, Yongxiang Wei & Zuoguang Wang. (2018) microRNA-21 and hypertension. Hypertension Research 41:9, pages 649-661.
Crossref
Crossref
Jamie G. Hijmans, Kyle J. Diehl, Tyler D. Bammert, Philip J. Kavlich, Grace M. Lincenberg, Jared J. Greiner, Brian L. Stauffer & Christopher A. DeSouza. (2018) Association between hypertension and circulating vascular-related microRNAs. Journal of Human Hypertension 32:6, pages 440-447.
Crossref
Crossref
Charlotte Farah, Lauriane Y. M. Michel & Jean-Luc Balligand. (2018) Nitric oxide signalling in cardiovascular health and disease. Nature Reviews Cardiology 15:5, pages 292-316.
Crossref
Crossref
Justyna Pordzik, Katarzyna Pisarz, Salvatore De Rosa, Axel Dyve Jones, Ceren Eyileten, Ciro Indolfi, Lukasz Malek & Marek Postula. (2018) The Potential Role of Platelet-Related microRNAs in the Development of Cardiovascular Events in High-Risk Populations, Including Diabetic Patients: A Review. Frontiers in Endocrinology 9.
Crossref
Crossref
Feng Gao, Fa‑Gang Wang, Ren‑Rong Lyu, Feng Xue, Jian Zhang & Ran Huo. (2018) SLC35E3 identified as a target of novel‑m1061‑5p via microRNA profiling of patients with cardiovascular disease. Molecular Medicine Reports.
Crossref
Crossref
Roopesh S Gangwar, Sanjay Rajagopalan, Rama Natarajan & Jeffrey A Deiuliis. (2018) Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics. American Journal of Hypertension 31:2, pages 150-165.
Crossref
Crossref
Hui-Feng Hao, Li-Mei Liu, Chun-Shui Pan, Chuan-She Wang, Yuan-Sheng Gao, Jing-Yu Fan & Jing-Yan Han. (2017) Rhynchophylline Ameliorates Endothelial Dysfunction via Src-PI3K/Akt-eNOS Cascade in the Cultured Intrarenal Arteries of Spontaneous Hypertensive Rats. Frontiers in Physiology 8.
Crossref
Crossref
Siguan Liu, Fanfan Yi, Wenwei Cheng, Xin Qu & Chunting Wang. (2017) Molecular mechanisms in vascular injury induced by hypertension: Expression and role of microRNA‑34a. Experimental and Therapeutic Medicine.
Crossref
Crossref
Fangqin Wu, Lu Li, Qiang Wen, Jinhua Yang, Zhuyue Chen, Peng Wu, Meian He, Xiaomin Zhang, Tangchun Wu & Longxian Cheng. (2017)
A functional variant in ST2 gene is associated with risk of hypertension
via
interfering MiR-202-3p
. Journal of Cellular and Molecular Medicine 21:7, pages 1292-1299.
Crossref
Crossref
Durairaj Sekar, B. R. Shilpa & Anupam J. Das. (2017) Relevance of microRNA 21 in Different Types of Hypertension. Current Hypertension Reports 19:7.
Crossref
Crossref
Ryszard Nosalski, Eilidh McGinnigle, Mateusz Siedlinski & Tomasz J. Guzik. (2017) Novel Immune Mechanisms in Hypertension and Cardiovascular Risk. Current Cardiovascular Risk Reports 11:4.
Crossref
Crossref
Coskun U. Oruc, Yunus E. Akpinar, Elmire Dervisoglu, Shirkhan Amikishiyev, Artur Salmaslıoglu, Figen Gurdol & Beyhan Omer. (2017) Low concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome. Clinical Chemistry and Laboratory Medicine (CCLM) 55:1, pages 139-144.
Crossref
Crossref
S. Friso, C.A. Carvajal, F. Pizzolo, C.E. Fardella & O. Olivieri. 2017. Translating Epigenetics to the Clinic. Translating Epigenetics to the Clinic
159
184
.
Danielle L. Michell & Kasey C. Vickers. (2016) HDL and microRNA therapeutics in cardiovascular disease. Pharmacology & Therapeutics 168, pages 43-52.
Crossref
Crossref
Jie Li, Xiao-Yong Geng & Xiao-Liang Cong. (2016) PGC-1α ameliorates AngiotensinII-induced eNOS dysfunction in human aortic endothelial cells. Vascular Pharmacology 83, pages 90-97.
Crossref
Crossref
Simon PR Romaine, Fadi J Charchar, Nilesh J Samani & Maciej Tomaszewski. (2016) Circulating microRNAs and hypertension—from new insights into blood pressure regulation to biomarkers of cardiovascular risk. Current Opinion in Pharmacology 27, pages 1-7.
Crossref
Crossref
Dildar Konukoglu & Hafize Uzun. 2017. Hypertension: from basic research to clinical practice. Hypertension: from basic research to clinical practice
511
540
.
Jun Wang, Xiaojun Bai, Qiang Song, Fenling Fan, Zhi Hu, Gesheng Cheng & Yushun Zhang. (2015) miR-223 Inhibits Lipid Deposition and Inflammation by Suppressing Toll-Like Receptor 4 Signaling in Macrophages. International Journal of Molecular Sciences 16:10, pages 24965-24982.
Crossref
Crossref